Abstract
Type 2 diabetes (T2D) as a multifactorial disease is characterized not only by chronic hyperglycaemia but also with defects in lipid and protein metabolism. These defects impact the utilization of glucose and non-esterified “free“ fatty acids (NEFA) by muscle, liver, and adipose tissue. Free fatty acids (FFA) represent an important link between obesity, insulin resistance, and T2D. Eleveted plasma concentration of FFA (especially saturated FFA) is associated with impaired insulin secretion and sensitivity and glucose intolerance.
The major objective of the present study was to investigate association of plasma free fatty acid profile in Type 2 diabetic subjects with different control of glycemia. This study involved 40 patients with T2D and 40 healthy subjects. Preparation of samples for FFA analysis was done by extraction and methanolysis of plasma lipids while detection and quantification of FFA concentrations was done by gas chromatography/mass spectrometry. Other biochemical analyses, including glucose, glycated hemoglobin (HbA1c), cholesterol, and triglycerides were done according to standard IFCC methods. A significant difference between T2D and control subjects was demonstrated only for palmitic acid (C16:0). There was a significant correlation of C16:0 with HbA1c levels (p<0.001) in patients with both adequate and poor T2D control. Also, a significant correlation was obtained at a level of plasma C18:1(p<0,05) and HbA1c level, only in patients with inadequate diabetes control. Thus, our data suggested that palmitic fatty acid (C16:0) and (C18:1) could serve as a potential biomarkers in optimal T2D management.
Access provided by CONRICYT-eBooks. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
References
Pankow JS, Duncan BB, Schmidt MI, Ballantyne CM, Couper DJ, Hoogeveen RC, Golden SH. Fasting plasma free fatty acids and risk of type 2 diabetes. Diabetes Care, Volume:27, 2004, pp77-82
Boden Guenther. Free fatty acids as target for therapy. Current Opinion in Endocrinology&Diabetes, Volume: 11, Issue:5, 2004, pp 258-263
Cnop M. Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes. Biochemical Society Transactions, Volume: 36, Issue:3, 2008, pp348-352
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet., Volume:1, Issue:7285, 1963, pp785-9.
Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes, Volume: 18, Issue:2, 2011, pp139-143
Ragheb R, Medhat AM. Mechanisms of fatty acid-induced insulin resistance in muscle and liver. J Diabetes Metab, Volume:2, 2011, pp127-132
Nigel Turner, Gregory J Cooney, Edward W Kraegen, and Clinton R Bruce. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. Journal of Endocrinology, Volume:220, 2014, pp61–79
Menni C, Fauman E, Erte I, Perry R.B. J, Kastenmüller G, Shin So-Youn, Petersen Ann-Kristin et al. Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach. Diabetes, Volume:62, 2013, pp4270–4276
Tan B, Liang Y, Yi L, Li H, Zhou Z, Ji X, Deng J. Identification of free fatty acids profiling of type 2 diabetes mellitus and exploring possible biomarkers by GC-MS coupled with chemometrics. Metabolomics, Volume:6, 2010, pp219-228
Lee JW, Kim HJ, Kwon YS, Jun YH, Kim SK, Choi JW, et al. Serum glycated albumin as a new glycemic marker in pediatric diabetes. Ann Pediatr Endocrinol Metab., Volume:18, 2013, pp208–213
Choi HJ, Jeon SY, Hong WK, Jung SE, Kang HJ, Kim JW, et al. Effect of glucose ingestion in plasma markers of inflammation and oxidative stress: analysis of 16 plasma markers from oral glucose tolerance test samples of normal and diabetic patients. Diabetes Res Clin Pract., Volume:99, 2013, pp27–31
Kontronen A, Velagapudi RV, Yetukuri L, Westerbacka J, Bergholm R, Ekroos K, Makkonen J et al. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations. Diabetologia, Volume:52, 2009, pp684-690
Source: Adapted from American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35 (Supp 1):S12, Table 2.
Guy Lepage and Claude C.Roy. Specific methylation of plasma nonesterified fatty acids in a one-step reaction. J. Lipid Res., Volume:27, 1986, pp 114-120
Kehlenbrink S, Koppaka S, Martin M, Relwani R, Cui MH, Hwang JH et al. Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. Diabetologia, Volume:55, 2012, pp3021-3028
Il’yasova D, Wang F, D’Agostino Jr RB, Hanley A, Wagenknecht. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia, Volume:53, 2010, pp866-874
Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycemic control in patients with abnormal glucose metabolism: A systematic review and meta-analysis. Ann Nutr Metab, Volume:58, 2011, pp290-296
Klop B, Elte JWF, Castro Cabezas M. Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients, Volume:5, 2013, pp1218-1240
Hansen D, Dendale P, Beelen M, Jonkers RAM, Mullens A, Corluy L, Meeusen R et al. Plasma adipokine and inflammation marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol, Volume:109, 2010, pp397-404
Wopereis S, Radonjic M, Rubingh C, van Erk M, Smilde A, Duyyvenvoorde van W, Cnubben N et al. Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice. Physiol Genomics, Volume:44, 2011, pp29-304
Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam Klaus-Peter, Milburn V. M, Kastenmüller Get al. Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance. Diabetes, Volume:62, 2013, pp1730–1737
John N. Clore, James Allred, Danielle White, Jing Li, Julie S. Stillman. The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus. Metabolism, Volume:51, Issue 11, 2002, pp1471-7.
John N. Clore, Julie S. Stillman, Jing Li, Stephen J. D. O’Keefe, James R. Levy. Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab, Volume:287, 2004, pp358–365
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Mandal, S., Causevic, A., Dzudzevic-Cancar, H., Semiz, S. (2017). Free fatty acid profile in Type 2 diabetic subjects with different control of glycemia. In: Badnjevic, A. (eds) CMBEBIH 2017. IFMBE Proceedings, vol 62. Springer, Singapore. https://doi.org/10.1007/978-981-10-4166-2_117
Download citation
DOI: https://doi.org/10.1007/978-981-10-4166-2_117
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4165-5
Online ISBN: 978-981-10-4166-2
eBook Packages: EngineeringEngineering (R0)